In line with this, in an in vitro pilot study we showed that 5-FU may lower the burden of MDSC in severe COVID-19 patients, casing a lowered production of IL-10, IL-8, IL-17, and Th2 cytokines, while increasing the production of IFN-γ and IL-2. This evidence concerns the gene IL17A and COVID-19.